The Biochemical Basis of Neurodegenerative Disease: The Role of Immunoexcitoxicity and Ways to Possibly Attenuate It

Overview

Journal Surg Neurol Int

Specialty Neurology

Date 2023 May 8

PMID 37151454

Authors

Russell L Blaylock

Affiliations

Soon will be listed here.

Abstract

There is growing evidence that inflammation secondary to immune activation is intimately connected to excitotoxicity. We now know that most peripheral tissues contain fully operational glutamate receptors. While most of the available research deals with excitotoxicity in central nervous system (CNS) tissues, this is no longer true. Even plant has been found to contain glutamate receptors. Most of the immune cells, including mask cells, contain glutamate receptors. The receptors are altered by inflammation, both chemokine and cytokines. A host of new diseases have been found that are caused by immunity to certain glutamate receptors, as we see with Rasmussen's encephalitis. In this paper, I try to explain this connection and possible ways to reduce or even stop the reaction.

References

Taylor C, Greenlund S, McGuire L, Lu H, Croft J . Deaths from Alzheimer's Disease - United States, 1999-2014. MMWR Morb Mortal Wkly Rep. 2017; 66(20):521-526. PMC: 5657871. DOI: 10.15585/mmwr.mm6620a1. View

Ganor Y, Levite M . The neurotransmitter glutamate and human T cells: glutamate receptors and glutamate-induced direct and potent effects on normal human T cells, cancerous human leukemia and lymphoma T cells, and autoimmune human T cells. J Neural Transm (Vienna). 2014; 121(8):983-1006. DOI: 10.1007/s00702-014-1167-5. View

Pacheco R, Gallart T, Lluis C, Franco R . Role of glutamate on T-cell mediated immunity. J Neuroimmunol. 2007; 185(1-2):9-19. DOI: 10.1016/j.jneuroim.2007.01.003. View

Dirscherl K, Karlstetter M, Ebert S, Kraus D, Hlawatsch J, Walczak Y . Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype. J Neuroinflammation. 2010; 7:3. PMC: 2819254. DOI: 10.1186/1742-2094-7-3. View

Kostic M, Zivkovic N, Cvetanovic A, Stojanovic I, colic M . IL-17 signalling in astrocytes promotes glutamate excitotoxicity: Indications for the link between inflammatory and neurodegenerative events in multiple sclerosis. Mult Scler Relat Disord. 2017; 11:12-17. DOI: 10.1016/j.msard.2016.11.006. View

Hovens I, van Leeuwen B, Nyakas C, Heineman E, van der Zee E, Schoemaker R . Prior infection exacerbates postoperative cognitive dysfunction in aged rats. Am J Physiol Regul Integr Comp Physiol. 2015; 309(2):R148-59. DOI: 10.1152/ajpregu.00002.2015. View

Rothstein J, Martin L, Kuncl R . Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992; 326(22):1464-8. DOI: 10.1056/NEJM199205283262204. View

Sattler R, Tymianski M . Molecular mechanisms of calcium-dependent excitotoxicity. J Mol Med (Berl). 2000; 78(1):3-13. DOI: 10.1007/s001090000077. View

Tobinick E, Kim N, Reyzin G, Rodriguez-Romanacce H, DePuy V . Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2012; 26(12):1051-70. DOI: 10.1007/s40263-012-0013-2. View

10.

DeGiorgio L, Konstantinov K, Lee S, Hardin J, Volpe B, Diamond B . A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med. 2001; 7(11):1189-93. DOI: 10.1038/nm1101-1189. View

11.

Vitkovic L, Bockaert J, Jacque C . "Inflammatory" cytokines: neuromodulators in normal brain?. J Neurochem. 2000; 74(2):457-71. DOI: 10.1046/j.1471-4159.2000.740457.x. View

12.

Wang Y, Luo J, Li S . Nano-Curcumin Simultaneously Protects the Blood-Brain Barrier and Reduces M1 Microglial Activation During Cerebral Ischemia-Reperfusion Injury. ACS Appl Mater Interfaces. 2019; 11(4):3763-3770. DOI: 10.1021/acsami.8b20594. View

13.

Takeuchi H, Jin S, Suzuki H, Doi Y, Liang J, Kawanokuchi J . Blockade of microglial glutamate release protects against ischemic brain injury. Exp Neurol. 2008; 214(1):144-6. DOI: 10.1016/j.expneurol.2008.08.001. View

14.

Gill S, Mueller R, McGuire P, Pulido O . Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity. Toxicol Pathol. 2000; 28(2):277-84. DOI: 10.1177/019262330002800207. View

15.

Raffaello A, Mammucari C, Gherardi G, Rizzuto R . Calcium at the Center of Cell Signaling: Interplay between Endoplasmic Reticulum, Mitochondria, and Lysosomes. Trends Biochem Sci. 2016; 41(12):1035-1049. PMC: 5123979. DOI: 10.1016/j.tibs.2016.09.001. View

16.

Naghashpour M, Jafarirad S, Amani R, Sarkaki A, Saedisomeolia A . Update on riboflavin and multiple sclerosis: a systematic review. Iran J Basic Med Sci. 2017; 20(9):958-966. PMC: 5651462. DOI: 10.22038/IJBMS.2017.9257. View

17.

Rojo-Sebastian A, Gonzalez-Robles C, Garcia de Yebenes J . Vitamin B6 Deficiency in Patients With Parkinson Disease Treated With Levodopa/Carbidopa. Clin Neuropharmacol. 2020; 43(5):151-157. DOI: 10.1097/WNF.0000000000000408. View

18.

Sperlagh B, Zsilla G, Baranyi M, Illes P, Vizi E . Purinergic modulation of glutamate release under ischemic-like conditions in the hippocampus. Neuroscience. 2007; 149(1):99-111. DOI: 10.1016/j.neuroscience.2007.07.035. View

19.

Powers H . Riboflavin (vitamin B-2) and health. Am J Clin Nutr. 2003; 77(6):1352-60. DOI: 10.1093/ajcn/77.6.1352. View

20.

Pinto J, Cooper A . From cholesterogenesis to steroidogenesis: role of riboflavin and flavoenzymes in the biosynthesis of vitamin D. Adv Nutr. 2014; 5(2):144-63. PMC: 3951797. DOI: 10.3945/an.113.005181. View